Carbamate poisoning: Difference between revisions
(Add MedicationDose entries for atropine, diazepam, pralidoxime) |
(Strip excess bold) |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
* | *Carbamates are N-methyl carbamate insecticides derived from carbamic acid | ||
*Structurally and mechanistically similar to [[organophosphates]] (OPs) but with critical differences in duration and reversibility<ref name="statpearls">Carbamate Toxicity. StatPearls [Internet]. NCBI Bookshelf. Updated May 1, 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK482183/</ref> | *Structurally and mechanistically similar to [[organophosphates]] (OPs) but with critical differences in duration and reversibility<ref name="statpearls">Carbamate Toxicity. StatPearls [Internet]. NCBI Bookshelf. Updated May 1, 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK482183/</ref> | ||
*Common agents: | *Common agents: | ||
| Line 20: | Line 20: | ||
===Mechanism of Action=== | ===Mechanism of Action=== | ||
*Carbamates | *Carbamates carbamylate the serine active site of [[acetylcholinesterase]] (AChE), preventing breakdown of acetylcholine | ||
*This results in acetylcholine accumulation → [[cholinergic crisis|cholinergic toxicity]] (identical toxidrome to [[Organophosphate toxicity]]) | *This results in acetylcholine accumulation → [[cholinergic crisis|cholinergic toxicity]] (identical toxidrome to [[Organophosphate toxicity]]) | ||
| Line 48: | Line 48: | ||
===Special Considerations: Tres Pasitos=== | ===Special Considerations: Tres Pasitos=== | ||
* | *Tres Pasitos ("Three Little Steps") is an illegally imported rodenticide containing aldicarb, one of the most toxic carbamates | ||
*Sold unlabeled in small groceries, particularly in Dominican, Caribbean, and Latin American communities in the US<ref name="trespasitos"/> | *Sold unlabeled in small groceries, particularly in Dominican, Caribbean, and Latin American communities in the US<ref name="trespasitos"/> | ||
*Patients may present without knowing what they ingested — | *Patients may present without knowing what they ingested — ask about rat poison specifically | ||
*Has caused mass poisoning events; patients may require high-dose atropine (>10 mg) and ICU admission<ref name="cdc_aldicarb">Poisonings associated with illegal use of aldicarb as a rodenticide — New York City, 1994-1997. ''MMWR Morb Mortal Wkly Rep''. 1997;46(41):961-963. PMID 9347907.</ref> | *Has caused mass poisoning events; patients may require high-dose atropine (>10 mg) and ICU admission<ref name="cdc_aldicarb">Poisonings associated with illegal use of aldicarb as a rodenticide — New York City, 1994-1997. ''MMWR Morb Mortal Wkly Rep''. 1997;46(41):961-963. PMID 9347907.</ref> | ||
| Line 58: | Line 58: | ||
*Identical [[cholinergic crisis|cholinergic toxidrome]] to [[Organophosphate toxicity]], but generally '''shorter duration''' and '''less CNS involvement'''<ref name="statpearls"/> | *Identical [[cholinergic crisis|cholinergic toxidrome]] to [[Organophosphate toxicity]], but generally '''shorter duration''' and '''less CNS involvement'''<ref name="statpearls"/> | ||
*Onset: minutes to hours depending on route (inhalation fastest, dermal slowest) | *Onset: minutes to hours depending on route (inhalation fastest, dermal slowest) | ||
*Duration: usually self-limited within | *Duration: usually self-limited within 6-12 hours; rarely up to 24 hours (due to spontaneous AChE reactivation) | ||
===Muscarinic Effects=== | ===Muscarinic Effects=== | ||
*SLUDGE(M) = | *SLUDGE(M) = Salivation, Lacrimation, Urination, Diarrhea, GI pain, Emesis, Miosis | ||
*DUMBELLS = | *DUMBELLS = Diarrhea/Diaphoresis, Urination, Miosis, Bradycardia/Bronchorrhea, Emesis, Lacrimation, Lethargic, Salivation | ||
*'''Killer B's''' = '''B'''radycardia, '''B'''ronchorrhea, '''B'''ronchospasm (leading causes of death) | *'''Killer B's''' = '''B'''radycardia, '''B'''ronchorrhea, '''B'''ronchospasm (leading causes of death) | ||
===Nicotinic Effects (NMJ)=== | ===Nicotinic Effects (NMJ)=== | ||
*MTWThF (days of week) = | *MTWThF (days of week) = Mydriasis/Muscle cramps, Tachycardia, Weakness, Twitching, Hypertension/Hyperglycemia, Fasciculations | ||
*'''Note''': Nicotinic effects (tachycardia, mydriasis) may mask classic muscarinic findings — do not rule out carbamate poisoning based on normal pupils or heart rate | *'''Note''': Nicotinic effects (tachycardia, mydriasis) may mask classic muscarinic findings — do not rule out carbamate poisoning based on normal pupils or heart rate | ||
| Line 75: | Line 75: | ||
===Cause of Death=== | ===Cause of Death=== | ||
* | *Respiratory failure from the combination of: | ||
**Bronchospasm and bronchorrhea (drowning in secretions) | **Bronchospasm and bronchorrhea (drowning in secretions) | ||
**Respiratory muscle weakness/paralysis (nicotinic effect) | **Respiratory muscle weakness/paralysis (nicotinic effect) | ||
| Line 90: | Line 90: | ||
==Evaluation== | ==Evaluation== | ||
===Workup=== | ===Workup=== | ||
* | *Point-of-care glucose — nicotinic-mediated hyperglycemia may occur; exclude hypoglycemia in altered patients | ||
*CBC — may show [[leukocytosis]] | *CBC — may show [[leukocytosis]] | ||
*Comprehensive Metabolic Panel | *Comprehensive Metabolic Panel | ||
| Line 100: | Line 100: | ||
===Diagnosis=== | ===Diagnosis=== | ||
* | *Clinical diagnosis based on history + cholinergic toxidrome | ||
* | *Attempt to identify the specific product: | ||
**Ask EMS to bring containers, labels, or Material Safety Data Sheets (MSDS) | **Ask EMS to bring containers, labels, or Material Safety Data Sheets (MSDS) | ||
**Distinguish carbamate vs OP whenever possible — this guides pralidoxime decisions | **Distinguish carbamate vs OP whenever possible — this guides pralidoxime decisions | ||
**Ask specifically about rat poisons, especially "Tres Pasitos" in appropriate populations<ref name="trespasitos"/> | **Ask specifically about rat poisons, especially "Tres Pasitos" in appropriate populations<ref name="trespasitos"/> | ||
* | *Atropine challenge: If diagnosis is uncertain, a trial dose of atropine (1 mg IV) that produces improvement supports the diagnosis of cholinesterase inhibitor poisoning<ref name="iemep"/> | ||
*Laboratory cholinesterase levels: | *Laboratory cholinesterase levels: | ||
**RBC AChE and plasma butyrylcholinesterase (BuChE) can be obtained but are | **RBC AChE and plasma butyrylcholinesterase (BuChE) can be obtained but are rarely available in time to guide acute management | ||
**'''Important caveat''': In carbamate poisoning, RBC AChE levels '''rapidly normalize in vitro''' because the carbamate-AChE bond is reversible — samples must be obtained quickly and cooled/frozen immediately, or false-negative results will occur<ref name="statpearls"/> | **'''Important caveat''': In carbamate poisoning, RBC AChE levels '''rapidly normalize in vitro''' because the carbamate-AChE bond is reversible — samples must be obtained quickly and cooled/frozen immediately, or false-negative results will occur<ref name="statpearls"/> | ||
**Levels may be more useful for retrospective confirmation and medicolegal purposes | **Levels may be more useful for retrospective confirmation and medicolegal purposes | ||
| Line 113: | Line 113: | ||
==Management== | ==Management== | ||
===Staff Safety and Decontamination=== | ===Staff Safety and Decontamination=== | ||
* | *Don PPE before patient contact — nitrile or neoprene gloves (latex is insufficient), gown, eye protection<ref name="iemep"/> | ||
*Remove ALL clothing and bag separately | *Remove ALL clothing and bag separately | ||
*Wash skin thoroughly with soap and water | *Wash skin thoroughly with soap and water | ||
* | *GI decontamination: Generally not recommended | ||
**Rapid absorption and profuse vomiting/diarrhea limit utility of activated charcoal and lavage<ref name="iemep"/> | **Rapid absorption and profuse vomiting/diarrhea limit utility of activated charcoal and lavage<ref name="iemep"/> | ||
**If very early presentation (<1 hour) with large ingestion and protected airway, single-dose activated charcoal may be considered | **If very early presentation (<1 hour) with large ingestion and protected airway, single-dose activated charcoal may be considered | ||
===Atropine=== | ===Atropine=== | ||
* | *First-line and most important antidote — muscarinic antagonist<ref name="rosman">Rosman Y, Makarovsky I, Bentur Y, Shrot S, Dushnistky T, Krivoy A. Carbamate poisoning: treatment recommendations in the setting of a mass casualties event. ''Am J Emerg Med''. 2009;27(9):1117-1124. PMID 19931761.</ref> | ||
* | *Does NOT reverse nicotinic symptoms (weakness, fasciculations, paralysis) | ||
*Starting dose: | *Starting dose: 1-2 mg IV (pediatric: 0.02-0.05 mg/kg, minimum 0.1 mg) | ||
* | *Doubling protocol: If inadequate response after 5 minutes, double the dose (1 → 2 → 4 → 8 mg...) until adequate atropinization | ||
*Severe cases (e.g. aldicarb) may require >10 mg total<ref name="trespasitos"/> | *Severe cases (e.g. aldicarb) may require >10 mg total<ref name="trespasitos"/> | ||
* | *Endpoints of adequate atropinization: | ||
**Drying of bronchial secretions ( | **Drying of bronchial secretions (most important endpoint) | ||
**Heart rate >80 bpm | **Heart rate >80 bpm | ||
**Systolic BP >80 mmHg | **Systolic BP >80 mmHg | ||
*'''Do NOT target''': Fully dilated pupils, absent bowel sounds, or HR >150 (these indicate atropine toxicity) | *'''Do NOT target''': Fully dilated pupils, absent bowel sounds, or HR >150 (these indicate atropine toxicity) | ||
*After initial atropinization: consider atropine infusion (10-20% of loading dose per hour) | *After initial atropinization: consider atropine infusion (10-20% of loading dose per hour) | ||
* | *Total atropine requirements are generally LESS than with OP poisoning due to shorter duration of carbamate toxicity | ||
* | *Optimize oxygenation before giving atropine to reduce risk of dysrhythmias | ||
===Pralidoxime (2-PAM): The Controversy=== | ===Pralidoxime (2-PAM): The Controversy=== | ||
* | *Pralidoxime is generally NOT indicated for confirmed carbamate poisoning<ref name="kurtz">Kurtz PH. Pralidoxime in the treatment of carbamate intoxication. ''Am J Emerg Med''. 1990;8(1):68-70. PMID 2403479.</ref> | ||
*Rationale: | *Rationale: | ||
**Carbamate-AChE binding is | **Carbamate-AChE binding is reversible and spontaneously regenerates → oximes are theoretically unnecessary | ||
**Pralidoxime has a different binding mechanism to carbamates than to OPs → no reactivation benefit<ref name="tn_poison"/> | **Pralidoxime has a different binding mechanism to carbamates than to OPs → no reactivation benefit<ref name="tn_poison"/> | ||
**Historical concern: Animal studies with | **Historical concern: Animal studies with carbaryl showed that pralidoxime alone worsened outcomes (protective ratio <1)<ref name="atsdr">Cholinesterase Inhibitors: Part 4 — Pralidoxime. Agency for Toxic Substances and Disease Registry (ATSDR), CDC. Available at: https://archive.cdc.gov/www_atsdr_cdc_gov/csem/cholinesterase-inhibitors/pralidoxime.html</ref> | ||
* | *However, important nuances: | ||
**The carbaryl concern was from | **The carbaryl concern was from a single carbamate tested with pralidoxime ALONE (without atropine) — when atropine was co-administered, outcomes improved<ref name="atsdr"/> | ||
**Recent case reports suggest pralidoxime may be safe and possibly beneficial in some carbamate poisonings when given with atropine<ref name="hoffman">Hoffman RS, Manini AF, Russell-Haders AL, Felberbaum M, Mercurio-Zappala M. Use of pralidoxime without atropine in rivastigmine (carbamate) toxicity. ''Clin Toxicol''. 2009;47(8):811-813. PMID 19755437.</ref> | **Recent case reports suggest pralidoxime may be safe and possibly beneficial in some carbamate poisonings when given with atropine<ref name="hoffman">Hoffman RS, Manini AF, Russell-Haders AL, Felberbaum M, Mercurio-Zappala M. Use of pralidoxime without atropine in rivastigmine (carbamate) toxicity. ''Clin Toxicol''. 2009;47(8):811-813. PMID 19755437.</ref> | ||
** | **Mixed exposures (carbamate + OP) are common (up to 35% of insecticide exposures) — pralidoxime is indicated for the OP component<ref name="atsdr"/> | ||
* | *Bottom line for the ED: | ||
{| class="wikitable" style="background:#ffffcc;" | {| class="wikitable" style="background:#ffffcc;" | ||
|- | |- | ||
| Line 214: | Line 214: | ||
==Disposition== | ==Disposition== | ||
*'''Most carbamate poisonings resolve within 6-12 hours''' (some up to 24 hours) due to spontaneous AChE reactivation<ref name="statpearls"/> | *'''Most carbamate poisonings resolve within 6-12 hours''' (some up to 24 hours) due to spontaneous AChE reactivation<ref name="statpearls"/> | ||
*Asymptomatic patients with | *Asymptomatic patients with minimal exposure: observe for a minimum of 6 hours; may discharge if remains asymptomatic | ||
* | *Admit all symptomatic patients — ICU admission for: | ||
**Need for atropine infusion or repeated dosing | **Need for atropine infusion or repeated dosing | ||
**Respiratory distress or intubation | **Respiratory distress or intubation | ||
| Line 221: | Line 221: | ||
**Seizures or altered mental status | **Seizures or altered mental status | ||
**Aldicarb or other highly toxic carbamate exposure | **Aldicarb or other highly toxic carbamate exposure | ||
*Unlike OP poisoning, intermediate syndrome and delayed neuropathy (OPIDN) are | *Unlike OP poisoning, intermediate syndrome and delayed neuropathy (OPIDN) are not expected — prolonged monitoring beyond 24 hours is usually not needed for confirmed carbamate-only exposures | ||
*If agent is | *If agent is unidentified: monitor as for OP poisoning (at least 24 hours; watch for delayed toxicity) | ||
*If evidence of deliberate self-harm → psychiatric hold and consult psychiatry | *If evidence of deliberate self-harm → psychiatric hold and consult psychiatry | ||
* | *Poison Control: 1-800-222-1222 (US) for all exposures | ||
===Consultant Pearls=== | ===Consultant Pearls=== | ||
* | *Toxicology: Call early — especially if agent is unknown or if considering pralidoxime. Ask about the specific product and whether it is carbamate, OP, or mixed | ||
*'''ICU/Critical Care''': For any patient requiring intubation, atropine infusion, or hemodynamic support | *'''ICU/Critical Care''': For any patient requiring intubation, atropine infusion, or hemodynamic support | ||
* | *Psychiatry: Mandatory for intentional ingestions | ||
*'''If EMS or family can identify the product label or MSDS''': This is '''extremely valuable''' — it distinguishes carbamate from OP and determines whether pralidoxime is indicated<ref name="statpearls"/> | *'''If EMS or family can identify the product label or MSDS''': This is '''extremely valuable''' — it distinguishes carbamate from OP and determines whether pralidoxime is indicated<ref name="statpearls"/> | ||
Latest revision as of 09:30, 22 March 2026
Background
- Carbamates are N-methyl carbamate insecticides derived from carbamic acid
- Structurally and mechanistically similar to organophosphates (OPs) but with critical differences in duration and reversibility[1]
- Common agents:
| WHO Toxicity Class | Agent | Notes |
|---|---|---|
| Ia — Extremely hazardous | Aldicarb (Temik) | LD50 0.8 mg/kg in humans; sold illicitly as "Tres Pasitos" (rodenticide)[2] |
| Ib — Highly hazardous | Carbofuran, Methomyl, Oxamyl | Commonly used in agriculture |
| II — Moderately hazardous | Carbaryl (Sevin), Propoxur (Baygon) | Widely available consumer products |
| III — Slightly hazardous | Pirimicarb, Fenobucarb | Lower toxicity profile |
| Medication | Rivastigmine, Pyridostigmine, Physostigmine, Neostigmine | Therapeutic carbamates; toxicity from overdose or patch misuse |
- Absorption via dermal, inhalational, and gastrointestinal routes[1]
Mechanism of Action
- Carbamates carbamylate the serine active site of acetylcholinesterase (AChE), preventing breakdown of acetylcholine
- This results in acetylcholine accumulation → cholinergic toxicity (identical toxidrome to Organophosphate toxicity)
Key Differences from Organophosphates
| Feature | Carbamates | Organophosphates |
|---|---|---|
| AChE binding | Reversible (spontaneous reactivation) | Irreversible (permanent without oxime) |
| Duration of toxicity | Usually <24 hours | Days to weeks |
| Aging | Does NOT occur | Occurs (time-dependent, compound-specific) |
| CNS penetration | Poor (most do not cross BBB well) | Good (significant CNS effects) |
| Pralidoxime role | Generally not needed; controversial | Indicated (before aging occurs) |
| Intermediate syndrome | Not reported | Can occur at 24-96 hours |
| Delayed neuropathy (OPIDN) | Not reported | Rare; 1-5 weeks post-exposure |
| Lab detection | RBC AChE rapidly normalizes in vitro | RBC AChE remains depressed |
- Clinical pearl: Despite being "reversible," severe carbamate poisoning (especially aldicarb) can absolutely be fatal — respiratory failure can occur before spontaneous enzyme reactivation[4]
Special Considerations: Tres Pasitos
- Tres Pasitos ("Three Little Steps") is an illegally imported rodenticide containing aldicarb, one of the most toxic carbamates
- Sold unlabeled in small groceries, particularly in Dominican, Caribbean, and Latin American communities in the US[2]
- Patients may present without knowing what they ingested — ask about rat poison specifically
- Has caused mass poisoning events; patients may require high-dose atropine (>10 mg) and ICU admission[5]
Autonomic Nervous System Receptors and Their Effects
- Parasympathetic - ACh is transm
- Muscarinic
- receptors in heart, eye, lung, GI, skin and sweat glands
- Bradycardia
- Miosis
- Bronchorrhea / Bronchospasm
- Hyperperistalsis (SLUDGE)
- Sweating
- Vasodilation
- Nicotinic
- receptors in both sympathetic and parasympathetic nervous systems
- fasciculations, flaccid paralysis
- ?Mild bradycardia, hypotension
- Muscarinic
- Sympathetic
- Alpha effects (vessels, eye, skin)
- Mydriasis, hypertension, sweating
- Beta effects (heart, lungs)
- Tachycardia, bronchodilation
- Alpha effects (vessels, eye, skin)
Clinical Features
- Identical cholinergic toxidrome to Organophosphate toxicity, but generally shorter duration and less CNS involvement[1]
- Onset: minutes to hours depending on route (inhalation fastest, dermal slowest)
- Duration: usually self-limited within 6-12 hours; rarely up to 24 hours (due to spontaneous AChE reactivation)
Muscarinic Effects
- SLUDGE(M) = Salivation, Lacrimation, Urination, Diarrhea, GI pain, Emesis, Miosis
- DUMBELLS = Diarrhea/Diaphoresis, Urination, Miosis, Bradycardia/Bronchorrhea, Emesis, Lacrimation, Lethargic, Salivation
- Killer B's = Bradycardia, Bronchorrhea, Bronchospasm (leading causes of death)
Nicotinic Effects (NMJ)
- MTWThF (days of week) = Mydriasis/Muscle cramps, Tachycardia, Weakness, Twitching, Hypertension/Hyperglycemia, Fasciculations
- Note: Nicotinic effects (tachycardia, mydriasis) may mask classic muscarinic findings — do not rule out carbamate poisoning based on normal pupils or heart rate
CNS Effects
- Generally less prominent than with OPs because most carbamates cross the blood-brain barrier poorly[6]
- When present: headache, confusion, agitation, seizures (more common with highly toxic agents like aldicarb)
- Respiratory depression — central drive suppression can still occur and is life-threatening
Cause of Death
- Respiratory failure from the combination of:
- Bronchospasm and bronchorrhea (drowning in secretions)
- Respiratory muscle weakness/paralysis (nicotinic effect)
- Central respiratory depression (with agents that cross BBB)
- Patients can die before spontaneous enzyme reactivation occurs — do not be falsely reassured by the "reversible" label[4]
Differential Diagnosis
- Carbamate and OP poisoning are clinically indistinguishable — differentiation requires history, product identification, or lab testing[1]
SLUDGE Syndrome
- Carbamate toxicity
- Mushroom toxicity, especially:
- Organophosphate toxicity
- Nerve agent
- Nicotine toxicity (look alike)
- Acetylcholinesterase inhibitor overdose (e.g in myasthenia gravis or post anesthesia reversal)
Weakness
- Neuromuscular weakness
- Upper motor neuron:
- CVA
- Hemorrhagic stroke
- Multiple sclerosis
- Amyotrophic Lateral Sclerosis (ALS) (upper and lower motor neuron)
- Lower motor neuron:
- Spinal and bulbar muscular atrophy (Kennedy's syndrome)
- Spinal cord disease:
- Infection (Epidural abscess)
- Infarction/ischemia
- Trauma (Spinal Cord Syndromes)
- Inflammation (Transverse Myelitis)
- Degenerative (Spinal muscular atrophy)
- Tumor
- Peripheral nerve disease:
- Neuromuscular junction disease:
- Muscle disease:
- Rhabdomyolysis
- Dermatomyositis
- Polymyositis
- Alcoholic myopathy
- Upper motor neuron:
- Non-neuromuscular weakness
- Can't miss diagnoses:
- ACS
- Arrhythmia/Syncope
- Severe infection/Sepsis
- Hypoglycemia
- Periodic paralysis (electrolyte disturbance, K, Mg, Ca)
- Respiratory failure
- Emergent Diagnoses:
- Symptomatic Anemia
- Severe dehydration
- Hypothyroidism
- Polypharmacy
- Malignancy
- Aortic disease - occlusion, stenosis, dissection
- Other causes of weakness and paralysis
- Acute intermittent porphyria (ascending weakness)
- Can't miss diagnoses:
Chemical weapons
- Blister chemical agents (Vesicants)
- Lewisite (L)
- Sulfur mustard (H)
- Phosgene oxime (CX)
- Pulmonary chemical agents (Choking agents)
- Incendiary agents
- Cyanide chemical weapon agents (Blood agents)
- Prussic acid (AKA hydrogen cyanide, hydrocyanic acid, or formonitrile)
- Nerve Agents (organophosphates)
- Acetylcholinesterase inhibitors
- Household and commercial pesticides (diazinon and parathion)
- G-series (sarin, tabun, soman)
- V-series (VX)
- Lacrimating or riot-control agents
- Pepper spray
- Chloroacetophenone
- CS
Symptomatic bradycardia
- Cardiac
- Inferior MI (involving RCA)
- Sick sinus syndrome
- Neurocardiogenic/reflex-mediated
- Increased ICP
- Vasovagal reflex
- Hypersensitive carotid sinus syndrome
- Intra-abdominal hemorrhage (i.e. ruptured ectopic)
- Metabolic/endocrine/environmental
- Hyperkalemia
- Hypothermia (Osborn waves on ECG)
- Hypothyroidism
- Hypoglycemia (neonates)
- Toxicologic
- Infectious/Postinfectious
- Other
Evaluation
Workup
- Point-of-care glucose — nicotinic-mediated hyperglycemia may occur; exclude hypoglycemia in altered patients
- CBC — may show leukocytosis
- Comprehensive Metabolic Panel
- VBG/ABG — assess for respiratory failure, acidosis
- CXR — pulmonary edema in severe cases
- ECG
- Sinus bradycardia, QT prolongation, AV block, ventricular dysrhythmias
- Continuous cardiac monitoring is essential
Diagnosis
- Clinical diagnosis based on history + cholinergic toxidrome
- Attempt to identify the specific product:
- Ask EMS to bring containers, labels, or Material Safety Data Sheets (MSDS)
- Distinguish carbamate vs OP whenever possible — this guides pralidoxime decisions
- Ask specifically about rat poisons, especially "Tres Pasitos" in appropriate populations[2]
- Atropine challenge: If diagnosis is uncertain, a trial dose of atropine (1 mg IV) that produces improvement supports the diagnosis of cholinesterase inhibitor poisoning[3]
- Laboratory cholinesterase levels:
- RBC AChE and plasma butyrylcholinesterase (BuChE) can be obtained but are rarely available in time to guide acute management
- Important caveat: In carbamate poisoning, RBC AChE levels rapidly normalize in vitro because the carbamate-AChE bond is reversible — samples must be obtained quickly and cooled/frozen immediately, or false-negative results will occur[1]
- Levels may be more useful for retrospective confirmation and medicolegal purposes
Management
Staff Safety and Decontamination
- Don PPE before patient contact — nitrile or neoprene gloves (latex is insufficient), gown, eye protection[3]
- Remove ALL clothing and bag separately
- Wash skin thoroughly with soap and water
- GI decontamination: Generally not recommended
- Rapid absorption and profuse vomiting/diarrhea limit utility of activated charcoal and lavage[3]
- If very early presentation (<1 hour) with large ingestion and protected airway, single-dose activated charcoal may be considered
Atropine
- First-line and most important antidote — muscarinic antagonist[7]
- Does NOT reverse nicotinic symptoms (weakness, fasciculations, paralysis)
- Starting dose: 1-2 mg IV (pediatric: 0.02-0.05 mg/kg, minimum 0.1 mg)
- Doubling protocol: If inadequate response after 5 minutes, double the dose (1 → 2 → 4 → 8 mg...) until adequate atropinization
- Severe cases (e.g. aldicarb) may require >10 mg total[2]
- Endpoints of adequate atropinization:
- Drying of bronchial secretions (most important endpoint)
- Heart rate >80 bpm
- Systolic BP >80 mmHg
- Do NOT target: Fully dilated pupils, absent bowel sounds, or HR >150 (these indicate atropine toxicity)
- After initial atropinization: consider atropine infusion (10-20% of loading dose per hour)
- Total atropine requirements are generally LESS than with OP poisoning due to shorter duration of carbamate toxicity
- Optimize oxygenation before giving atropine to reduce risk of dysrhythmias
Pralidoxime (2-PAM): The Controversy
- Pralidoxime is generally NOT indicated for confirmed carbamate poisoning[8]
- Rationale:
- Carbamate-AChE binding is reversible and spontaneously regenerates → oximes are theoretically unnecessary
- Pralidoxime has a different binding mechanism to carbamates than to OPs → no reactivation benefit[6]
- Historical concern: Animal studies with carbaryl showed that pralidoxime alone worsened outcomes (protective ratio <1)[9]
- However, important nuances:
- The carbaryl concern was from a single carbamate tested with pralidoxime ALONE (without atropine) — when atropine was co-administered, outcomes improved[9]
- Recent case reports suggest pralidoxime may be safe and possibly beneficial in some carbamate poisonings when given with atropine[10]
- Mixed exposures (carbamate + OP) are common (up to 35% of insecticide exposures) — pralidoxime is indicated for the OP component[9]
- Bottom line for the ED:
| If confirmed pure carbamate poisoning → Atropine alone is usually sufficient; pralidoxime is generally not needed |
| If the agent is UNKNOWN or mixed OP/carbamate → Treat empirically with BOTH atropine AND pralidoxime (pralidoxime is unlikely to be harmful when atropine is co-administered)[1] |
| When in doubt → Treat as Organophosphate toxicity (the more dangerous entity) |
Benzodiazepines
- Diazepam 5-10 mg IV or midazolam for seizures
- Pediatric: diazepam 0.2-0.5 mg/kg IV
- Do NOT use phenytoin — ineffective for cholinergic seizures[7]
Supportive Care
- Airway management: Early intubation for copious secretions, respiratory failure, or altered mental status
- Large-bore suction is critical — patients may drown in secretions[11]
- Avoid succinylcholine — metabolized by plasma cholinesterase (inhibited by carbamates) → prolonged paralysis
- Use non-depolarizing agents (e.g. rocuronium) if RSI is needed
- IV fluid resuscitation for hypotension (from fluid losses, vasodilation)
- Vasopressors if refractory hypotension
- Continuous cardiac monitoring and pulse oximetry
- Avoid: morphine, theophylline, aminophylline, phenothiazines, reserpine[11]
Medication Dosing
Atropine 1-2mg IV, double dose q5min until drying of secretions IV Atropine 0.02-0.05mg/kg IV (min 0.1mg), double q5min until drying of secretions IV Diazepam 5-10mg IV IV Diazepam 0.2-0.5mg/kg IV IV Pralidoxime 20mg/kg (max 2g) IV over 30min, then 8-10mg/kg/hr (max 650mg/hr) IV
Disposition
- Most carbamate poisonings resolve within 6-12 hours (some up to 24 hours) due to spontaneous AChE reactivation[1]
- Asymptomatic patients with minimal exposure: observe for a minimum of 6 hours; may discharge if remains asymptomatic
- Admit all symptomatic patients — ICU admission for:
- Need for atropine infusion or repeated dosing
- Respiratory distress or intubation
- Hemodynamic instability
- Seizures or altered mental status
- Aldicarb or other highly toxic carbamate exposure
- Unlike OP poisoning, intermediate syndrome and delayed neuropathy (OPIDN) are not expected — prolonged monitoring beyond 24 hours is usually not needed for confirmed carbamate-only exposures
- If agent is unidentified: monitor as for OP poisoning (at least 24 hours; watch for delayed toxicity)
- If evidence of deliberate self-harm → psychiatric hold and consult psychiatry
- Poison Control: 1-800-222-1222 (US) for all exposures
Consultant Pearls
- Toxicology: Call early — especially if agent is unknown or if considering pralidoxime. Ask about the specific product and whether it is carbamate, OP, or mixed
- ICU/Critical Care: For any patient requiring intubation, atropine infusion, or hemodynamic support
- Psychiatry: Mandatory for intentional ingestions
- If EMS or family can identify the product label or MSDS: This is extremely valuable — it distinguishes carbamate from OP and determines whether pralidoxime is indicated[1]
See Also
- Organophosphate toxicity
- Toxidromes
- Cholinergic crisis
- Nerve agent
- Atropine
- Pralidoxime
- Acetylcholinesterase inhibitors
External Links
- Carbamate Toxicity — StatPearls
- Tres Pasitos — National Pesticide Information Center
- N-Methyl Carbamate Insecticides — EPA
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Carbamate Toxicity. StatPearls [Internet]. NCBI Bookshelf. Updated May 1, 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK482183/
- ↑ 2.0 2.1 2.2 2.3 Nelson LS, Perrone J, DeRoos F, Stork C, Hoffman RS. Aldicarb poisoning by an illicit rodenticide imported into the United States: Tres Pasitos. J Toxicol Clin Toxicol. 2001;39(5):447-452. PMID 11545234.
- ↑ 3.0 3.1 3.2 3.3 Organophosphate and Carbamate Poisoning (2024). International Emergency Medicine Education Project. December 26, 2024. Available at: https://iem-student.org/2024/12/20/organophosphate-and-carbamate-poisoning-2024/
- ↑ 4.0 4.1 Cholinergic Crisis after Rodenticide Poisoning. Western Journal of Emergency Medicine. 2014;15(2):185-187. Available at: https://westjem.com/case-report/cholinergic-crisis-after-rodenticide-poisoning.html
- ↑ Poisonings associated with illegal use of aldicarb as a rodenticide — New York City, 1994-1997. MMWR Morb Mortal Wkly Rep. 1997;46(41):961-963. PMID 9347907.
- ↑ 6.0 6.1 Williams S. Why does pralidoxime (2PAM) NOT work for patients poisoned with carbamates? Tennessee Poison Center. November 29, 2010. Available at: https://www.vumc.org/poison-control/toxicology-question-week/nov-29-2010-why-does-pralidoxime-2pam-not-work-patients-poisoned
- ↑ 7.0 7.1 Rosman Y, Makarovsky I, Bentur Y, Shrot S, Dushnistky T, Krivoy A. Carbamate poisoning: treatment recommendations in the setting of a mass casualties event. Am J Emerg Med. 2009;27(9):1117-1124. PMID 19931761.
- ↑ Kurtz PH. Pralidoxime in the treatment of carbamate intoxication. Am J Emerg Med. 1990;8(1):68-70. PMID 2403479.
- ↑ 9.0 9.1 9.2 Cholinesterase Inhibitors: Part 4 — Pralidoxime. Agency for Toxic Substances and Disease Registry (ATSDR), CDC. Available at: https://archive.cdc.gov/www_atsdr_cdc_gov/csem/cholinesterase-inhibitors/pralidoxime.html
- ↑ Hoffman RS, Manini AF, Russell-Haders AL, Felberbaum M, Mercurio-Zappala M. Use of pralidoxime without atropine in rivastigmine (carbamate) toxicity. Clin Toxicol. 2009;47(8):811-813. PMID 19755437.
- ↑ 11.0 11.1 N-Methyl Carbamate Insecticides, Chapter 6. US Environmental Protection Agency. Available at: https://www.epa.gov/sites/default/files/documents/rmpp_6thed_ch6_carbamates.pdf
